CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Quarterly Operating Income (Loss) in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Charles River Laboratories International, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2010 to Q3 2024.
  • Charles River Laboratories International, Inc. Operating Income (Loss) for the quarter ending September 28, 2024 was $117M, a 22.5% decline year-over-year.
  • Charles River Laboratories International, Inc. Operating Income (Loss) for the twelve months ending September 28, 2024 was $528M, a 18.5% decline year-over-year.
  • Charles River Laboratories International, Inc. annual Operating Income (Loss) for 2023 was $617M, a 5.18% decline from 2022.
  • Charles River Laboratories International, Inc. annual Operating Income (Loss) for 2022 was $651M, a 10.4% increase from 2021.
  • Charles River Laboratories International, Inc. annual Operating Income (Loss) for 2021 was $590M, a 36.3% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $528M $117M -$34.1M -22.5% Jun 30, 2024 Sep 28, 2024 10-Q 2024-11-06
Q2 2024 $562M $152M -$13.3M -8.06% Mar 31, 2024 Jun 29, 2024 10-Q 2024-08-07
Q1 2024 $575M $126M -$41.9M -25% Dec 31, 2023 Mar 30, 2024 10-Q 2024-05-09
Q4 2023 $617M $133M -$30.9M -18.9% Oct 1, 2023 Dec 30, 2023 10-K 2024-02-14
Q3 2023 $648M $152M +$526K +0.35% Jul 2, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 $648M $165M -$22.5M -12% Apr 2, 2023 Jul 1, 2023 10-Q 2024-08-07
Q1 2023 $670M $168M +$19.1M +12.8% Jan 1, 2023 Apr 1, 2023 10-Q 2024-05-09
Q4 2022 $651M $164M -$9M -5.21% Sep 25, 2022 Dec 31, 2022 10-K 2024-02-14
Q3 2022 $660M $151M -$4.83M -3.1% Jun 26, 2022 Sep 24, 2022 10-Q 2023-11-08
Q2 2022 $665M $187M +$49.9M +36.2% Mar 27, 2022 Jun 25, 2022 10-Q 2023-08-09
Q1 2022 $615M $149M +$25.1M +20.3% Dec 26, 2021 Mar 26, 2022 10-Q 2023-05-11
Q4 2021 $590M $173M +$43.9M +34% Sep 26, 2021 Dec 25, 2021 10-K 2024-02-14
Q3 2021 $546M $156M +$23M +17.4% Jun 27, 2021 Sep 25, 2021 10-Q 2022-11-02
Q2 2021 $523M $138M +$60.8M +79.2% Mar 28, 2021 Jun 26, 2021 10-Q 2022-08-03
Q1 2021 $462M $124M +$29.4M +31.2% Dec 27, 2020 Mar 27, 2021 10-Q 2022-05-04
Q4 2020 $433M $129M +$20.1M +18.5% Sep 27, 2020 Dec 26, 2020 10-K 2021-02-17
Q3 2020 $413M $133M +$40M +43.1% Jun 28, 2020 Sep 26, 2020 10-Q 2021-11-03
Q2 2020 $373M $76.8M -$3M -3.76% Mar 29, 2020 Jun 27, 2020 10-Q 2021-08-04
Q1 2020 $376M $94.3M +$24.5M +35.1% Dec 29, 2019 Mar 28, 2020 10-Q 2021-05-04
Q4 2019 $351M $109M +$6.31M +6.15% Sep 29, 2019 Dec 28, 2019 10-K 2021-02-17
Q3 2019 $345M $92.8M +$8.44M +10% Jun 30, 2019 Sep 28, 2019 10-K 2021-02-17
Q2 2019 $336M $79.8M +$3.06M +3.99% Mar 31, 2019 Jun 29, 2019 10-K 2021-02-17
Q1 2019 $333M $69.8M +$1.96M +2.89% Dec 30, 2018 Mar 30, 2019 10-K 2021-02-17
Q4 2018 $331M $102M +$39.7M +63.1% Sep 30, 2018 Dec 29, 2018 10-K 2020-02-11
Q3 2018 $292M $84.4M +$10.3M +13.9% Jul 1, 2018 Sep 29, 2018 10-K 2020-02-11
Q2 2018 $281M $76.7M -$4.98M -6.09% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-11
Q1 2018 $286M $67.8M -$1.88M -2.69% Dec 31, 2017 Mar 31, 2018 10-K 2020-02-11
Q4 2017 $288M $62.8M -$6.26M -9.07% Oct 1, 2017 Dec 30, 2017 10-K 2019-02-13
Q3 2017 $295M $74.1M +$15.3M +26% Jul 2, 2017 Sep 30, 2017 10-K 2019-02-13
Q2 2017 $279M $81.7M +$23.6M +40.7% Apr 2, 2017 Jul 1, 2017 10-K 2019-02-13
Q1 2017 $256M $69.7M +$18.2M +35.4% Jan 1, 2017 Apr 1, 2017 10-K 2019-02-13
Q4 2016 $237M $69.1M +$16.8M +32.2% Sep 25, 2016 Dec 31, 2016 10-K 2018-02-13
Q3 2016 $221M $58.8M +$3.36M +6.05% Jun 26, 2016 Sep 24, 2016 10-K 2018-02-13
Q2 2016 $217M $58.1M +$2.33M +4.17% Mar 27, 2016 Jun 25, 2016 10-K 2018-02-13
Q1 2016 $215M $51.5M +$8.47M +19.7% Dec 27, 2015 Mar 26, 2016 10-K 2018-02-13
Q4 2015 $206M $52.3M +$11.5M +28.2% Sep 27, 2015 Dec 26, 2015 10-K 2017-02-14
Q3 2015 $195M $55.4M +$9.27M +20.1% Jun 28, 2015 Sep 26, 2015 10-K 2017-02-14
Q2 2015 $186M $55.7M +$4.71M +9.23% Mar 29, 2015 Jun 27, 2015 10-K 2017-02-14
Q1 2015 $181M $43M +$3.3M +8.31% Dec 28, 2014 Mar 28, 2015 10-K 2017-02-14
Q4 2014 $178M $40.8M +$16.2M +65.7% Sep 28, 2014 Dec 27, 2014 10-K 2016-02-12
Q3 2014 $162M $46.2M +$5.33M +13% Jun 29, 2014 Sep 27, 2014 10-K 2016-02-12
Q2 2014 $156M $51M +$7.84M +18.1% Mar 30, 2014 Jun 28, 2014 10-K 2016-02-12
Q1 2014 $148M $39.7M -$3.06M -7.15% Dec 29, 2013 Mar 29, 2014 10-K 2016-02-12
Q4 2013 $151M $24.6M -$10.5M -29.8% Sep 29, 2013 Dec 28, 2013 10-K 2015-02-17
Q3 2013 $162M $40.8M +$3.16M +8.39% Jun 30, 2013 Sep 28, 2013 10-K 2015-02-17
Q2 2013 $159M $43.2M -$6.09M -12.4% Mar 31, 2013 Jun 29, 2013 10-K 2015-02-17
Q1 2013 $165M $42.8M -$977K -2.23% Dec 30, 2012 Mar 30, 2013 10-K 2015-02-17
Q4 2012 $166M $35.1M -$6.58M -15.8% Sep 30, 2012 Dec 29, 2012 10-K 2015-02-17
Q3 2012 $172M $37.7M +$588K +1.59% Jul 1, 2012 Sep 29, 2012 10-Q 2013-10-30
Q2 2012 $172M $49.3M -$4.04M -7.58% Apr 1, 2012 Jun 30, 2012 10-Q 2013-07-31
Q1 2012 $176M $43.7M +$1.49M +3.52% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-08
Q4 2011 $174M $41.6M +$407M Sep 25, 2011 Dec 31, 2011 10-K 2014-02-25
Q3 2011 -$233M $37.1M +$30.6M +474% Jun 26, 2011 Sep 24, 2011 10-Q 2012-11-01
Q2 2011 -$263M $53.3M +$23.3M +77.8% Mar 27, 2011 Jun 25, 2011 10-Q 2012-08-07
Q1 2011 -$286M $42.3M +$12.1M +39.9% Dec 26, 2010 Mar 26, 2011 10-Q 2012-05-04
Q4 2010 -$299M -$365M Sep 26, 2010 Dec 25, 2010 10-K 2013-02-27
Q3 2010 $6.47M Jun 27, 2010 Sep 25, 2010 10-Q 2011-11-02
Q2 2010 $30M Mar 28, 2010 Jun 26, 2010 10-Q 2011-08-03
Q1 2010 $30.2M Dec 27, 2009 Mar 27, 2010 10-Q 2011-05-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.